This year’s Drugs to Watch™ list from Clarivate™ is made up almost entirely of personalized medicines, treatments targeted to a particular biomarker, ensuring greater efficacy and less precious time lost searching for a drug or biologic that will arrest or reverse the progress of disease.
Among the major factors shaping the global pharmaceutical market in 2023 are increasing demand for biologics from Mainland China, the rise of biosimilars, progress toward personalized medicines and the urgency of addressing the diseases highlighted in the United Nations Sustainable Development Goals .
Access global intelligence, advanced analytics and global experts from Clarivate.